Egypt Strengthens African Cooperation to Localize Vaccine Manufacturing and Health Security
The Egyptian Drug Authority (EDA) participated in the fifth edition of the Africa Health ExCon 2026, which serves as a vital platform for enhancing health cooperation among the nations of the African continent. Dr. Ali Al-Ghamrawy, Chairman of the Egyptian Drug Authority, represented the authority at this prominent medical event.
The conference witnessed the signing of a series of significant strategic partnerships aimed primarily at localizing vaccine manufacturing within the African continent. This step comes as part of Egypt's ongoing efforts to transfer advanced medical technology, which contributes to reducing reliance on imports from abroad.
These initiatives are part of Egypt's strategy to strengthen health security in Africa, as the authority seeks to provide essential medicines and vaccines in a sustainable manner. Through these partnerships, Egypt aims to support African countries in addressing health crises and developing infrastructure for the pharmaceutical industries.
At the conclusion of the events, officials emphasized that these agreements represent a pivotal step toward achieving medical self-sufficiency. Egypt continues to play its leading role in ensuring access to healthcare and safe vaccines for all the continent's peoples, thereby reinforcing Egypt's position as a regional hub for pharmaceutical industries.